The clinical course of EGFR‐mutated NSCLC is influenced by a range of factors, including smoking history, histological subtype, EGFR mutation type, metastatic status, and patient performance status [6, 7, 8, 9]. Here, EGFR is linked to non-small cell lung carcinoma.